博猫平台注册网址代理

"At Technoclone we see innovation as our duty to help overcome new complexity in the diagnostics of hematological and cardio-vascular disorders. Since 1987, we have been in close collaboration with our global partners from academia, clinical laboratories and industry and on the forefront of diagnostic challenges of tomorrow." N. B. Binder MD PhD, CSO Technoclone